openPR Logo
Press release

Global Irritable Bowel Syndrome Treatment Market to Score Past US$ 2,300 Million Valuation by 2027 | At a CAGR of 12.9% | CMI

02-08-2021 08:34 AM CET | Health & Medicine

Press release from: Coherent Market Insights

Irritable Bowel Syndrome Treatment Market

Irritable Bowel Syndrome Treatment Market

Coherent Market Insights has recently added a new research report to its mega database of research studies. The research report, titled “Global Irritable Bowel Syndrome Treatment Market Report 2020 is latest research report, highlighting opportunities, risk side analysis, and leveraged with strategic and tactical decision-making support. The study provides information on market trends and development, drivers, capacities, technologies, and on the changing investment structure of the Global Irritable Bowel Syndrome Treatment Market.

Additionally, the Irritable Bowel Syndrome Treatment market 2020 report diagnosis the competitive layout of the world Irritable Bowel Syndrome Treatment market, comprising an outline of the major industry players, followed by their business strategies, policies, financial aspects and current market developments.

Request for a sample of this research report @ 
https://www.coherentmarketinsights.com/insight/request-sample/506

According to the Anxiety and Depression Association of America, approximately one in five adults in the U.S. is suffering with irritable bowel syndrome. Irritable bowel syndrome shows a wide range of symptoms, so, the treatment is decided on predominance of the symptoms such as, in pain predominant patients, antispasmodic agents or tricyclic antidepressants are used. The prevalence of irritable bowel syndrome is predominant in female than in males. According to the International Foundation for Functional Gastrointestinal Disorders, 2 in 3 IBS sufferers are female. Some of the U.S. Food & Drug Administration approved drugs for relieving the symptoms associated with IBS are Lotronex (Alosetron), Amitiza (Lubiprostone), Linzess (Linclotide), and Xifaxan (Rifaximin).

Some of the key players profiled in the study are Abbott Laboratories, Synergy Pharmaceuticals, Inc., Sucampo Pharmaceuticals, Inc., Valeant Pharmaceuticals International, Inc., Ardelyx, Inc., Astellas Pharma Inc., Novartis AG, GlaxoSmithKline plc., and Ironwood Pharmaceuticals, Inc.

Detailed Segmentation:

By Drug Type:

Lubiprostone
Linaclotide
Eluxadoline
Rifaximin
Ramosetron Hydrochloride
Others

By Medical Condition:

IBS-Constipation
IBS-Diarrhea

By Distribution Channel:

Hospital Pharmacies
Online Pharmacies
Retail Pharmacies

If opting for the Global version of Irritable Bowel Syndrome Treatment Market analysis is provided for major regions as follows: 

North America (The US, Canada, and Mexico)

Europe (the UK, Germany, France, and Rest of Europe)

Asia Pacific (China, India, and Rest of Asia Pacific)

Latin America (Brazil and Rest of Latin America)

Middle East & Africa (Saudi Arabia, the UAE, South Africa, and Rest of Middle East & Africa)

Get up to 30% Discount on this Premium Report @:
https://www.coherentmarketinsights.com/insight/request-discount/506

Important years considered in the study are:

Historical year – 2016-2019

Base year – 2020

Forecast period** – 2020 to 2027 [** unless otherwise stated]

Key Answers Captured in Study are

Which geography would have better demand for product/services?

What strategies of big players help them acquire share in regional market?

Countries that may see the steep rise in CAGR & year-on-year (Y-O-Y) growth?

How feasible is market for long term investment?

What opportunity the country would offer for existing and new players in the Irritable Bowel Syndrome Treatment market?

Risk side analysis involved with suppliers in specific geography?

What influencing factors driving the demand of Irritable Bowel Syndrome Treatment near future?

What is the impact analysis of various factors in the Global Irritable Bowel Syndrome Treatment market growth?

What are the recent trends in the regional market and how successful they are?

Apply Promo Code “STAYHOME” and Get Up to 30% Discount

Buy This Complete A Business Report:
https://www.coherentmarketinsights.com/insight/buy-now/506

There are 15 Chapters to display the Global Irritable Bowel Syndrome Treatment market.

Chapter 1, About Executive Summary to describe Definition, Specifications and Classification of Global Irritable Bowel Syndrome Treatment market, Applications.

Chapter 2, objective of the study.

Chapter 3, to display Research methodology and techniques.

Chapter 4 and 5, to show the Irritable Bowel Syndrome Treatment Market Analysis, segmentation analysis, characteristics;

Chapter 6 and 7, to show Five forces (bargaining Power of buyers/suppliers), Threats to new entrants and market condition;

Chapter 8 and 9, to show analysis by regional segmentation[North America Country (United States, Canada), South America, Asia Country (China, Japan, India, Korea), Europe Country (Germany, UK, France, Italy) & Other Country (Middle East, Africa, GCC) ], comparison, leading countries and opportunities; Regional Marketing Type Analysis, Supply Chain Analysis

Chapter 10, to identify major decision framework accumulated through Industry experts and strategic decision makers;

Chapter 11 and 12, Global Irritable Bowel Syndrome Treatment Market Trend Analysis, Drivers, Challenges by consumer behavior, Marketing Channels

Chapter 13 and 14, about vendor landscape (classification and Market Ranking)

Chapter 15, deals with Global Irritable Bowel Syndrome Treatment Market sales channel, distributors, Research Findings and Conclusion, appendix and data source.

Read Detailed Index of full Research Study at @ https://www.coherentmarketinsights.com/market-insight/irritable-bowel-syndrome-treatment-market-506

Coherent Market Insights 1001 4th Ave,
#3200 Seattle, WA 98154,U.S.
Phone: US +1-206-701-6702/UK +44-020 8133 4027
Email: sales@coherentmarketinsights.com

About Us:

Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Global Irritable Bowel Syndrome Treatment Market to Score Past US$ 2,300 Million Valuation by 2027 | At a CAGR of 12.9% | CMI here

News-ID: 2237630 • Views:

More Releases from Coherent Market Insights

Current Sensor Market Set to Witness Significant Growth by 2025-2032 - Coherent Market Insights
Current Sensor Market Set to Witness Significant Growth by 2025-2032 - Coherent …
The Current Sensor market is estimated to be valued at USD 3.42 Bn in 2025 and is expected to reach USD 6.75 Bn by 2032, growing at a compound annual growth rate CAGR of 10.2% from 2025 to 2032. ➤ Coherent Market Insights has published an in-depth research report titled "Current Sensor Market: Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2025-2032." This study offers a deep dive into the Current
U.S. Bodyguard Service & Security Consulting Market Evolution by 2032 - Disruptive Innovations, Regional Insights, and Growth Opportunities
U.S. Bodyguard Service & Security Consulting Market Evolution by 2032 - Disrupti …
The U.S. Bodyguard Service & Security Consulting market is estimated to be valued at USD 2.57 Bn in 2025 and is expected to reach USD 3.52 Bn by 2032, growing at a compound annual growth rate CAGR of 4.6% from 2025 to 2032. ➤ Coherent Market Insights has published an in-depth research report titled "U.S. Bodyguard Service & Security Consulting Market: Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2025-2032." This
Single Cell Sequencing Market Set for Dynamic Boom as Key Players Illumina, BD Biosciences, Pacific Biosciences, Thermo Fisher Scientific
Single Cell Sequencing Market Set for Dynamic Boom as Key Players Illumina, BD B …
The qualitative latest Research report (2025-2032) on the Single Cell Sequencing Market 2025 - 2032 by Coherent Market Insights Provides a deep dive into key market trends, drivers, challenges, and the competitive landscape. It analyzes market size, revenue, production, and CAGR using validated methodologies to ensure precision. The report highlights tech innovation, pricing trends, consumer behavior, and investment potential - empowering businesses to make informed, strategic moves. ➤ Request a Sample
Nuclear Medicine Equipment Market Set for Demonstrate Strong Growth During 2025-2032 with Key Players GE Healthcare, Siemens Healthineers, Philips, and Canon Medical Systems
Nuclear Medicine Equipment Market Set for Demonstrate Strong Growth During 2025- …
The qualitative latest Research report (2025-2032) on the Nuclear Medicine Equipment Market 2025 - 2032 by Coherent Market Insights Provides a deep dive into key market trends, drivers, challenges, and the competitive landscape. It analyzes market size, revenue, production, and CAGR using validated methodologies to ensure precision. The report highlights tech innovation, pricing trends, consumer behavior, and investment potential - empowering businesses to make informed, strategic moves. ➤ Request a Sample

All 5 Releases


More Releases for Irritable

Irritable Bowel Syndrome Medication Market Massive Growth opportunity Ahead
Exactitude Consultancy., Ltd. announces the release of the report "Global Irritable Bowel Syndrome Medication Market 2025 by Manufacturers, Regions, Type and Application, Forecast to 2034". The report is a detailed and comprehensive analysis presented by region and country, type and application. As the market is constantly changing, the report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets.
Irritable Bowel Syndrome (IBS) Treatment Market Grows Amidst Escalating Prevalen …
What combination of drivers is leading to accelerated growth in the irritable bowel syndrome (ibs) treatment market? The increase in irritable bowel syndrome (IBS) commonness is anticipated to spur the advancement of the IBS treatment market in the future. IBS is a persistent condition that impacts the large intestine. This uptick in IBS occurrence can be attributed to unhealthy lifestyles, poor dietary practices, exposure to pollutants, and elevated stress levels. The
Irritable Bowel Syndrome Treatment Market | $2 Billion by 2026
The market for treating irritable bowel syndrome (IBS) has witnessed significant growth in recent years. In 2018, the estimated value of the IBS treatment market was $1,071 million. However, with increasing awareness and advancements in medical research, the market is projected to reach a staggering $2,012 million by 2026. This represents a remarkable compound annual growth rate (CAGR) of 8.2% during the forecast period from 2019 to 2026. Irritable bowel syndrome
Global Irritable Bowel Syndrome Treatment Market Strategical Analysis Report 202 …
The primary purpose of the statistical analysis is to use data analysis and descriptive statistics. It helps to summarize data from a sample using indexes like mean or standard deviation and inferential statistics. This report includes information and statistics on price levels, location of the product, and demand for the product. The best thing about the statistical analysis report is that it allows businesses to make decisions in terms of
Irritable Bowel Syndrome (IBS) Treatment Market: Increasing Prevalence of Irrita …
The major factors such as the increasing prevalence of irritable bowel syndrome diseases and rising research & development activities drive the market growth. However, the limited number of product availability and treatment inefficiency restrain the market growth. IBS is a common chronic condition that affects the abdominal organ, large intestine. It is also known as spastic colon, mucous colitis, irritable colon, and spastic colitis. The condition is much different than
Ayurvedic Cure For Irritable Bowel Syndrome (IBS) Without Operation
The Grocare is a leading natural solution provider for chronic lifestyle diseases – Irritable bowel syndrome (IBS), is a gift of enterprise, and commitment to quality and modern-day buyers’ changing needs. Grocare conforms to stringent quality-related compliances and cost-efficient processes in all aspects of formulation and production. At Grocare, we use natural ingredients developed over the years of research and development. It is FDA certified, safe to use, and affordable